India to Japan: Amlodipine Export Trade Route
India has recorded 168 verified shipments of Amlodipine exported to Japan, representing a combined trade value of $14.5M USD. This corridor is served by 4 active Indian exporters, with an average shipment value of $86.2K USD. The leading Indian exporter is MEDREICH LIMITED, which accounts for 89% of total export value with 96 shipments worth $12.9M USD. On the buying side, MEIJI SEIKA PHARMATECH CO., LTD is the largest importer in Japan with $7.1M USD in purchases. The top 3 suppliers — MEDREICH LIMITED, MEDREICH LIMITED , LUPIN LIMITED — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Japan Amlodipine corridor is one of India's established pharmaceutical export routes, with 168 shipments documented worth a combined $14.5M USD. The route is dominated by MEDREICH LIMITED, which alone accounts for roughly 89% of all export value, reflecting the consolidated nature of India's amlodipine manufacturing sector.
Across 4 active suppliers, the average shipment value stands at $86.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 85% of all shipments, consistent with amlodipine's non-urgent bulk-order profile.
Shipment activity peaks during UNAVAILABLE, with an average transit time of 26 days port-to-port. The route has recorded an annual growth rate of 9.4%, placing it at rank #13 among India's top amlodipine export destinations globally.
On the import side, key buyers of Indian amlodipine in Japan include MEIJI SEIKA PHARMATECH CO., LTD, MEIJI SEIKA PHARMA CO LIMITED, MEIJI SEIKA PHARMA CO LTD ODAWARA and 16 others. MEIJI SEIKA PHARMATECH CO., LTD is the single largest importer with 49 shipments valued at $7.1M USD.
